Fred M. Tileston Jr., CEO of RABOME (USA), graduated from Stanford University with a Bachelor's degree in Industrial Engineering, an MBA in Marketing and Finance, a Doctor of Laws degree, and a lawyer's license. He is a senior management talent in business development and start-ups, specializing in company establishment, sales arrangements, investment and financing, as well as international law and economic law. He is a member of the State Bar of California and has 40 years of extensive experience in business operations such as helping client companies start up, conduct marketing, sell products, and formulate strategic plans for large and medium-sized enterprises. His professional fields include business plan writing, business development, structured financing, agreement negotiation, and company acquisition/sale.

 The Bone and Joint Regenerative Medicine Co., Ltd. (RABOME), founded by Mr. Fred M. Tileston Jr. and Mr. Chen Jiwei, is headquartered in San Francisco, USA. It is a world-leading company with biopharmaceutical technology R&D capabilities and technology platforms. Relying on the University of California, Davis, it has built a world-class biomedical laboratory and a team of American academician scientists and internationally renowned consultants. With years of R&D experience in the field of osteology, the company has established long-term and stable cooperative relationships with world-renowned pharmaceutical companies, biotechnology companies, hospitals and famous universities around the world to carry out cooperation in various osteological projects.